Abstract
When patients who have frequent, disabling migraines take medications to relieve their symptoms, they run the risk that the attacks will increase in frequency to daily or near-daily as a rebound effect comes into play. This pattern, called medication overuse headache, is more likely to happen with butalbital and opioids than with migraine-specific drugs, as partial responses lead to recurrence, repeat dosing, and, eventually, overuse. Breaking the cycle involves weaning the patient from the overused medications, setting up a preventive regimen, and setting strict limits on the use of medications to relieve acute symptoms.
Publication types
-
Research Support, Non-U.S. Gov't
-
Review
MeSH terms
-
Analgesics, Opioid / administration & dosage
-
Analgesics, Opioid / adverse effects*
-
Barbiturates / administration & dosage
-
Barbiturates / adverse effects*
-
Disease Susceptibility
-
Headache Disorders, Secondary / chemically induced*
-
Headache Disorders, Secondary / prevention & control*
-
Humans
-
Migraine Disorders / drug therapy*
-
Patient Education as Topic
-
Recurrence
-
Risk Factors
-
Substance Withdrawal Syndrome
-
Substance-Related Disorders / prevention & control*
-
Terminology as Topic
-
Tryptamines / administration & dosage
-
Tryptamines / adverse effects*
Substances
-
Analgesics, Opioid
-
Barbiturates
-
Tryptamines
-
butalbital